Kevin Robert Lind

Insider Reports History

Location
San Diego, CA
Signature
/s/ Donald R. Reynolds, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Robert Lind:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Longboard Pharmaceuticals, Inc. President and CEO, Director Common Stock 0 $0 $60.00 02 Dec 2024 Direct
Longboard Pharmaceuticals, Inc. President and CEO, Director Stock Option (Right to Buy) 255K 13 Nov 2024 Direct
Avalo Therapeutics, Inc. Director Stock Option (Right to Buy) 40.2K 01 Oct 2025 Direct
Longboard Pharmaceuticals, Inc. President and CEO, Director Retention Restricted Stock Units 22K 25 Oct 2024 Direct
Longboard Pharmaceuticals, Inc. President and CEO, Director Employee Stock Option (right to buy) 0 02 Dec 2024 Direct
Longboard Pharmaceuticals, Inc. President and CEO, Director Restricted Stock Unit 0 02 Dec 2024 Direct

Insider Reports Filed by Kevin Robert Lind

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVTX Avalo Therapeutics, Inc. 01 Oct 2025 1 $0 4 Director 02 Oct 2025, 16:23
AVTX Avalo Therapeutics, Inc. 01 Oct 2025 0 $0 3 Director 02 Oct 2025, 16:18
LBPH Longboard Pharmaceuticals, Inc. 02 Dec 2024 6 -$21.8M 4 President and CEO, Director 02 Dec 2024, 19:17
LBPH Longboard Pharmaceuticals, Inc. 13 Nov 2024 3 $40K 4 CEO, Director 13 Nov 2024, 20:48
LBPH Longboard Pharmaceuticals, Inc. 25 Oct 2024 1 $0 4 CEO, Director 29 Oct 2024, 16:38
LBPH Longboard Pharmaceuticals, Inc. 12 Aug 2024 4 $260K 4 CEO, Director 13 Aug 2024, 18:03
LBPH Longboard Pharmaceuticals, Inc. 08 Feb 2024 1 $0 4 CEO, Director 09 Feb 2024, 16:06
LBPH Longboard Pharmaceuticals, Inc. 09 Feb 2023 1 $0 4 CEO, Director 10 Feb 2023, 15:27
LBPH Longboard Pharmaceuticals, Inc. 09 Feb 2022 1 $0 4 CEO, Director 11 Feb 2022, 15:48